Summary of Product Characteristics
last updated on the eMC:
11/07/2011
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 11/07/2011 and displayed until Current
|
Reasons for adding or updating:
|
-
Change due to harmonisation of SPC
|
| Date of revision of text on the SPC: 27-Apr-2011 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| To update the SPC in line with the reference product, Semi Daonil 2.5mg & 5 mg tablets, sanofi-aventis Ireland Ltd.
|
|
Updated on 18/05/2010 and displayed until 11/07/2011
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
| Date of revision of text on the SPC: |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
